REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 169 filers reported holding REGENXBIO INC in Q1 2020. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $10,932 | +16.5% | 482 | +35.8% | 0.00% | 0.0% |
| Q3 2022 | $9,383 | +7.0% | 355 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $8,769 | -50.2% | 355 | -33.0% | 0.00% | -50.0% |
| Q1 2022 | $17,591 | +23.4% | 530 | +21.6% | 0.01% | +20.0% |
| Q4 2021 | $14,257 | -21.1% | 436 | +1.2% | 0.01% | -28.6% |
| Q3 2021 | $18,068 | -27.8% | 431 | -33.1% | 0.01% | -22.2% |
| Q2 2021 | $25,019 | +95.2% | 644 | +85.1% | 0.01% | +28.6% |
| Q2 2020 | $12,817 | +182.7% | 348 | +148.6% | 0.01% | +133.3% |
| Q1 2020 | $4,533 | -74.0% | 140 | -67.1% | 0.00% | -66.7% |
| Q4 2019 | $17,412 | +74.1% | 425 | +51.2% | 0.01% | +50.0% |
| Q3 2019 | $10,004 | -49.3% | 281 | -18.3% | 0.01% | -50.0% |
| Q1 2019 | $19,715 | +27.0% | 344 | -7.0% | 0.01% | +20.0% |
| Q4 2018 | $15,522 | -49.7% | 370 | -9.5% | 0.01% | -50.0% |
| Q3 2018 | $30,880 | +13.3% | 409 | +7.6% | 0.02% | +5.3% |
| Q2 2018 | $27,265 | – | 380 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |